Peptides Unit
Buy Peptides Retatrutide Semaglutide Tirzepatide Online
- Quality Peptides
- Fast and Secure Shipping
- Buy Now In USA, Canada, Australia, UK
- Worldwide delivery
Buy Weight Loss Refill Pens
Semaglutide
Semaglutide
Semaglutide
Tirzepatide
Tirzepatide
muscle growth
Retatrutide
Retatrutide
Retatrutide
Pens
Recommended Dosage
The Science of Transformation: GLP-1s & Peptides
Trusted Laboratory Testing of Anabolics, Peptides and More…
Harm reduction chemical analysis for anyone committed to their health and performance.
How It works
Buy Weight Loss Refill Pens
Peptides
Peptides
Peptides
Peptides
Peptides
Peptides
Peptides
Where we move beyond fad diets and unsustainable workouts. We specialize in evidence-based medical weight management utilizing the latest advancements in GLP-1 agonists and peptide therapies.
Superiority to Single and Dual Agonists
| Compound | Mechanism | Weight Loss (48-72 weeks) |
|---|---|---|
| Semaglutide | GLP-1 only | ~14.9% |
| Tirzepatide | GIP + GLP-1 | ~21% |
| Retatrutide | GIP + GLP-1 + Glucagon | ~24.2% |
Standard Titration Protocol
| Week | Dose per Injection | Frequency | Total Weekly |
|---|---|---|---|
| 1-2 | 0.25mg | 2x | 0.5mg |
| 3-4 | 0.5mg | 2x | 1.0mg |
| 5-8 | 1.0mg | 2x | 2.0mg |
| 9+ | 2.0-4.0mg | 2x | 4.0-8.0mg |
1. Semaglutide: The Gold Standard in Appetite Regulation
Semaglutide (branded as Ozempic® or Wegovy®) is a GLP-1 receptor agonist that revolutionized obesity medicine. It works by:
Mimicking GLP-1: A natural hormone that targets areas of the brain regulating appetite.
Slowing Gastric Emptying: Helping you feel fuller for longer.
Results: Patients typically see a 10–15% reduction in total body weight when combined with lifestyle intervention.
2. Retatrutide: The Triple-Hormone Revolution
Currently making waves in clinical research, Retatrutide is the first triple-hormone receptor agonist (GLP-1, GIP, and Glucagon).
The "Triple Agonist": By activating the glucagon receptor, Retatrutide not only suppresses appetite but also increases energy expenditure.
Fat Reduction: Early data suggests this is one of the most powerful tools for reducing liver fat and visceral adipose tissue.
For Advanced Patients: Ideal for those with significant metabolic resistance who have not achieved desired results with dual agonists.
3. Tirzepatide: Dual-Action Superiority
Tirzepatide (Mounjaro®) represents a leap forward in efficacy. As a dual GIP and GLP-1 receptor agonist, it offers a two-pronged attack on metabolic dysfunction.
Dual Agonist: Combines the appetite suppression of GLP-1 with the metabolic benefits of GIP (Glucose-dependent Insulinotropic Polypeptide).
Enhanced Efficacy: Clinical trials show superior weight loss results compared to Semaglutide alone, often exceeding 20% total body weight loss.
Metabolic Health: Significantly improves insulin sensitivity and cholesterol profiles.
The Triple-Agonist Mechanism
What sets Retatrutide apart from other research peptides is its unique ability to activate three key metabolic receptors simultaneously:
| Receptor | Primary Effects |
|---|---|
| GLP-1R (Glucagon-Like Peptide-1) | Enhances insulin secretion, suppresses appetite, delays gastric emptying, reduces food intake |
| GIPR (Glucose-dependent Insulinotropic Polypeptide) | Stimulates insulin release, influences fat metabolism, works synergistically with GLP-1 |
| GCGR (Glucagon Receptor) | Increases energy expenditure, promotes lipolysis (fat breakdown), reduces liver fat accumulation |
This triple activation creates a synergistic effect that addresses metabolic dysfunction from multiple angles—appetite suppression, enhanced insulin sensitivity, and increased energy expenditure—making it a uniquely valuable tool for preclinical research
Rigorously Tested Purity
≥99% purity verified by HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry Batch-specific Certificates of Analysis (COAs) available for review Third-party testing to ensure product integrity
Research-Use Only Compliance
Products strictly intended for in vitro and preclinical research Full documentation to support laboratory compliance Transparent labeling and handling instructions
Secure and Discreet Shipping
Lyophilized (freeze-dried) powder for optimal stability. Temperature-controlled packaging to preserve peptide integrity. Global shipping with tracking
Expert Support
Dedicated customer service for research inquiries Technical assistance for reconstitution and storage protocols
In the rapidly evolving field of metabolic science, Retatrutide—also known by its research code LY3437943—has emerged as one of the most promising investigational compounds of the decade. As the first triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously, Retatrutide represents a paradigm shift in obesity and metabolic disorder research .
If you are looking to buy Retatrutide for legitimate laboratory research, PeptidesUnit.com offers premium-grade, rigorously tested compounds designed to support cutting-edge scientific investigation.
What is Retatrutide?
Retatrutide is a 39-amino-acid synthetic peptide engineered from a GIP backbone, incorporating three non-coded amino acid residues that provide enhanced stability and receptor-binding specificity . Its molecular formula is C₂₂₁H₃₄₂N₄₆O₆₈, with a molecular weight of 4,731.33 g/mol and CAS number 2381089-83-2
Research-Backed Efficacy: What the Science Shows
Retatrutide has generated significant attention in the scientific community due to compelling clinical trial results:
Unprecedented Weight Reduction
In a landmark Phase 2 trial published in the New England Journal of Medicine, participants receiving the highest dose (12 mg weekly) achieved:
24.2% mean weight reduction at 48 weeks
Approximately 58 pounds (26.4 kg) lost on average
Weight loss trajectory had not plateaued by study end
Glycemic Control and Metabolic Health
100% of participants with prediabetes at baseline in the 8 mg and 12 mg groups reverted to normal glycemic status
Significant reductions in systolic and diastolic blood pressure
Improved lipid profiles: decreased triglycerides, increased HDL cholesterol
86% reduction in liver fat content among participants with NAFLD
Additional Research Applications
Beyond obesity and diabetes research, Retatrutide is being investigated for:
Non-alcoholic fatty liver disease (NAFLD) and NASH
Cardiovascular risk factors
Metabolic syndrome and insulin resistance
Sleep apnea (ongoing Phase 3 TRIUMPH trials)
Knee osteoarthritis in the context of obesity
Retatrutide Specifications
| Property | Details |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight | 4731.33 g/mol |
| Sequence | H-Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ |
| Purity | ≥99% (HPLC verified) |
| Format | Lyophilized powder |
| Storage | -20°C (long-term), refrigerated after reconstitution |
| Intended Use | Research / Laboratory Use Only |
Storage and Handling Guidelines
To maintain the integrity and stability of Retatrutide for your research:
Lyophilized Powder
Store at -20°C (freezer) upon arrival
Protect from light and moisture
Stable for extended periods when unopened and properly stored
Reconstituted Solution
Use bacteriostatic water or sterile water for reconstitution
Store at 2-8°C (refrigerated)
Use within 7-14 days for optimal stability
Avoid repeated freeze-thaw cycles
Handling Tips
Allow vial to reach room temperature before reconstitution
Gently swirl—do not shake vigorously
Use sterile techniques to prevent contamination
Safety and Quality Assurance
Regulatory Compliance
PeptidesUnit.com adheres to strict guidelines for research compounds:
Products sold strictly for research purposes only
Not intended for human consumption or therapeutic use
Compliance with applicable laboratory safety standards
Quality Control
Each batch undergoes:
HPLC purity analysis (≥99%)
Mass Spectrometry for sequence verification
Endotoxin testing to ensure suitability for cell-based assays
Sterility testing where applicable
Documentation
Certificate of Analysis (COA) available per batch
Material Safety Data Sheet (MSDS) included
Product specifications and handling guidelines
Frequently Asked Questions
Q: Is Retatrutide FDA-approved?
A: No. Retatrutide is an investigational compound currently in Phase 3 clinical trials. It is not approved by the FDA or any other regulatory agency for human use. PeptidesUnit.com sells Retatrutide strictly for research purposes only .
Q: What is the half-life of Retatrutide?
A: Retatrutide has an extended half-life of approximately 6 days, supporting once-weekly administration in research protocols .
Q: How should I store Retatrutide?
A: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2-8°C and use within 7-14 days .
Q: What purity level can I expect?
A: PeptidesUnit.com provides Retatrutide with ≥99% purity, verified by HPLC analysis with batch-specific COAs .
Q: Do I need special credentials to purchase?
A: PeptidesUnit.com sells to qualified researchers and institutions. Proof of research affiliation may be required to ensure compliance with research-use-only regulations.
Q: Can Retatrutide be used for cell-based assays?
A: Yes. Our high-purity, endotoxin-tested Retatrutide is suitable for various in vitro applications, including cell culture studies and receptor-binding assays.
Order Retatrutide Today
Advance your metabolic research with the highest-quality Retatrutide available. Whether you are investigating the triple-agonist mechanism, exploring NAFLD interventions, or conducting comparative studies with other incretin mimetics, PeptidesUnit.com provides the reliability and purity your research demands.
Buy Retatrutide at PeptidesUnit.com and experience:
Premium ≥99% purity
Verified quality documentation
Secure and discreet shipping
Expert customer support
Product Availability
| Product | Size | Purity | Format |
|---|---|---|---|
| Retatrutide | 5mg | ≥99% | Lyophilized Powder |
| Retatrutide | 10mg | ≥99% | Lyophilized Powder |
| Retatrutide | 20mg | ≥99% | Lyophilized Powder |
| Retatrutide | 50mg | ≥99% | Lyophilized Powder |
Bulk inquiries and custom quantities available upon request.
References
Retatrutide—A Game Changer in Obesity Pharmacotherapy. NIH/PMC. 2025
Retatrutide; 2381089-83-2 Product Information. ChemicalBook. 2026
Retatrutide Dosing for Beginners. Kilo Biotechnology. 2025
Retatrutide: Triple Agonist Peptide for Metabolic Aging. AMD Alliance. 2026
The Power of Three: Retatrutide’s Role in Modern Obesity and Diabetes Therapy. ScienceDirect. 2024